CUTANEOUS SQUAMOUS CELL CARCINOMA

Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 6 Completed 6 Terminated 4

New trial targets tough skin cancer in vulnerable patients

Disease control Not yet recruiting

This study is testing the safety and effectiveness of an already FDA-approved skin cancer drug called cosibelimab in two special groups of patients with advanced skin cancer. The first group includes people who have had a kidney transplant, and the second includes people who also…

Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA

Phase: PHASE4 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

CUTANEOUS SQUAMOUS CELL CARCINOMA

Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear

New trial targets tough skin cancer in vulnerable patients